Access to safe abortion within the limits of the law

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 20, Issue 3, 2006, Pages 421-432

  Rao, Kamini A ^a   Faúndes, Anibal ^b  

^a Bangalore Assisted Conception Centre   (India)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

abortion; human rights; method for abortion induction; sexual and reproductive rights; unsafe abortion

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ABORTION; DRUG EFFICACY; GYNECOLOGY; HEALTH HAZARD; HUMAN; HUMAN RIGHTS ABUSE; LAMINARIA; LAW; LEGAL ASPECT; MEDICAL SPECIALIST; OBSTETRICS; PATIENT SAFETY; PREGNANCY TERMINATION; PRIORITY JOURNAL; REVIEW; STANDARD; UNWANTED PREGNANCY; WOMEN'S RIGHTS; WORLD HEALTH ORGANIZATION;

ABORTION, CRIMINAL; ABORTION, LEGAL; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMAN RIGHTS; HUMANS; PREGNANCY; PREGNANCY, UNWANTED; REPRODUCTIVE RIGHTS; WOMEN'S HEALTH; WOMEN'S RIGHTS;

EID: 33746532632     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2006.01.020     Document Type: Review

References (52)

1. World Health Organization. Recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths: modifications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand 56 (1977) 247-253
2. Schenker J.G., and Cain J.M. International Federation of Gynecology and Obstetrics Committee for the ethical aspects of human reproduction and women's health. Int J Gynaecol Obstet 64 (1999) 317-322
3. AbouZahr C., and Ahman E. Unsafe abortion and ectopic pregnancy. In: Murray C.J.L., and Lopez A.D. (Eds). Health Dimensions of Sex and Reproduction: the Global Burden of Sexually Transmitted Diseases, HIV, Maternal Conditions, Perinatal Disorders, and Congenital Anomalies (1998), Harvard University, Cambridge, MA 266-296
4. Report of the International Conference on Population and Development, Cairo, 5-13 September 1994. United Nations publication, Sales No. E.95.XIII.18. Chap. I, Resolution 1, Annex. NY: United Nations; 1995.
5. World Health Organization. Safe Abortion: Technical and Policy Guidance for Health Systems. 1st edn (2003), WHO, Geneva pp. 106
6. Department for Economic and Social Information and Policy Analysis. World Population Prospects: the 2000 Revision (2001), United Nations, New York
7. Henshaw S.K., Singh S., and Haas T. The incidence of abortion worldwide. Int Fam Plann Perspect 25 supplement (1999) 30-38
8. Faúndes A., and Barzelatto J. The Human Drama of Abortion: a Global Search for Consensus. 1st edn (2006), Vanderbilt University Press, Norman, Oklahoma
9. World Health Organization. Unsafe Abortion: Global and Regional Estimates of Incidence of Unsafe Abortion and Associated Mortality in 2000. 4th edn (2004). http://www.who.int/reproductive-health/publications/unsafe_abortion_esti mates_04/estimates.pdf Last accessed 20 January 2006
10. The Alan Guttmacher Institute. Sharing Responsibility. Women, Society and Abortion Worldwide. p. 37 (1999). http://www.agi-usa.org/pubs/sharing.pdf Last accessed 20 January 2006
11. Richards A., Lachman E., Pitsoe S.B., and Moodley J. The incidence of major abdominal surgery after septic abortion - an indicator of complications due to illegal abortion. S Afr Med J 68 (1985) 799-800
12. Briozzo L., Rodriguez F., Leon I., Vidiella G., Ferreiro G., and Pons J.E. Unsafe abortion in Uruguay. Int J Gynaecol Obstet 85 (2004) 70-73
13. World Health Organization. Unsafe Abortion: Global and Regional Estimates of Incidence of and Mortality Due to Unsafe Abortion with a Listing of Available Country Data. 3rd edn (1997), World Health Organization, Division of Reproductive Health (Technical Support), Geneva
14. Faúndes A., Santos L.C., Carvalho M., and Gras C. Post abortion complications after interruption of preganancy with misoprostol. Adv Contracept 12 (1996) 1-9
15. Viggiano M., Faúndes A., Borges A.L., Viggiano A.B.F., Souza G.R., and Rebello I. Disponibilidade de misoprostol e complicações de aborto provocado em Goiânia. Jornal brasileiro de Ginecologia 106 (1996) 55-61
16. Zhirova I.A., Frolova O.G., Astakhova T.M., and Ketting E. Abortion-related maternal mortality in the Russian Federation. Stud Fam Plann 35 (2004) 178-188
17. Grimes D.A., and Schulz K.F. Morbidity and mortality from second-trimester abortions. J Reprod Med 30 (1985) 505-514
18. Nagaya K., Fetters M.D., Ishikawa M., et al. Causes of maternal mortality in Japan. JAMA 283 (2000) 2661-2667
19. Tietze C., and Henshaw S.K. Induced Abortion: A World Review. 6th edn (1986), The Alan Guttmacher Institute, New York Table 1, pp. 12-14
20. Stephenson P., Wagner M., Badea M., and Serbanescu F. Commentary: The public health consequences of restricted induced abortion. Lessons from Romania. Am J Public Health 82 (1992) 1328-1331
21. United Nations. Report of the Fourth World Conference on Women. Beijing, 4-15 September 1995. NY: United Nations; 1995.
22. Committee on the Elimination of Discrimination against Women. General recommendation 24: Women and Health (20th Sess., 1999), in Compilation of General Comments and General Recommendations by Human Rights Treaty Bodies, at 244, §11, U.N. Doc. HRI/GEN/1/Rev.5 (2001).
23. Cook R., Dickens B.M., and Fathalla M.F. Reproductive Health and Human Rights (2003), Oxford University Press, New York pp. 351-353
24. von Hertzen H., Honkanen J., Piaggio G., et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. Br J Obstet Gynaecol 110 (2003) 808-818
25. Honkanen H., Piaggio G., Hertzen H., et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. Br J Obstet Gynaecol 111 (2004) 715-725
26. Kulier R., Gulmezoglu A.M., Hofmeyr G.J., Cheng L.N., and Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev (2004) CD002855
27. Nothnagle M., and Taylor J.S. Medical methods for first-trimester abortion. Am Fam Physician 70 (2004) 81-83
28. Stubblefield P.G., Carr-Ellis S., and Borgatta L. Methods for induced abortion. Obstet Gynecol 104 (2004) 174-185
29. Cates W., Grimes D.A., Smith J.C., and Tyler C.W. Legal abortion mortality in the United States: epidemiologic surveillance, 1972-1974. JAMA 237 (1997) 452-455
30. Hart G., and Macharper T. Clinical aspects of induced abortion in South Australia from 1970 to 1984. Aust NZ J Obstet Gynaecol 26 (1986) 219-224
31. Greenslade F.C., Benson J., Winkler J., Henderson V., Wolf M., and Leonard A. Summary of clinical and programmatic experience with manual vacuum aspiration. IPAS (Carrboro, NC) 3 (1993) 1-4
32. Autry A.M., Hayes E.C., Jacobson G.F., and Kirby R.S. A comparison of medical induction and dilation and evacuation for second-trimester abortion. Am J Obstet Gynecol 187 (2002) 393-397
33. Stubblefield P.G., Carr-Ellis S., and Borgatta L. Methods for induced abortion. Obstet Gynecol 105 (2005) 221-222
34. Tang O.S., Mok K.H., and Ho P.C. A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester. Hum Reprod 19 (2004) 1101-1104
35. Goldberg A.B., Drey E.A., Whitaker A.K., et al. Misoprostol compared with laminaria before early second-trimester surgical abortion: a randomized trial. Obstet Gynecol 106 (2005) 234-241
36. Bugalho A., Bique C., Almeida L., and Faúndes A. The effectiveness of intravaginal misoprostol (Cytotec) in inducing abortion after eleven weeks of pregnancy. Stud Fam Plann 24 (1993) 319-323
37. Ngai S.W., Tang O.S., and Ho P.C. Prostaglandins for induction of second-trimester termination and intrauterine death. Best Pract Res Clin Obstet Gynaecol 17 (2003) 765-775
38. Tang O.S., and Ho P.C. Medical abortion in the second trimester. Best Pract Res Clin Obstet Gynaecol 16 (2002) 237-246
39. Tang O.S., Lau W.N., Chan C.C., and Ho P.C. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. Br J Obstet Gynaecol 111 (2004) 1001-1005
40. Tang O.S., Chan C.C., Kan A.S., and Ho P.C. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation. Hum Reprod 20 (2005) 3062-3066
41. Hamoda H., Ashok P.W., Flett G.M., and Templeton A. Hum Reprod 20 (2005) 2348-2354
42. Grimes D.A., Smith M.S., and Witham A.D. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial. Br J Obstet Gynaecol 111 (2004) 148-153
43. Velazco A. Aborto Terapéutico. In: Faundes A (Ed). Uso de misoprostol em Obstetrícia y Ginecologia (2005), Federación Latinoamericana de Sociedades de Ginecologia y Obstetrícia, Santa Cruz, Bolívia 61-78
44. le Roux P.A., Pahal G.S., Hoffman L., et al. Second trimester termination of pregnancy for fetal anomaly or death: comparing mifepristone/misoprostol to gemeprost. Eur J Obstet Gynecol Reprod Biol 95 (2001) 52-54
45. Berghahn L., Christensen D., and Droste S. Uterine rupture during second-trimester abortion associated with misoprostol. Obstet Gynecol 98 (2001) 976-977
46. Daskalakis G.J., Mesogitis S.A., Papantoniou N.E., et al. Misoprostol for second trimester pregnancy termination in women with prior cesarean section. Br J Obstet Gynaecol 112 (2005) 97-99
47. Nayki U., Taner C.E., and Mizrak T. Uterine rupture during second trimester abortion with misoprostol. Fetal Diagn Ther 20 (2005) 469-471
48. Herabutya Y., Chanarachakul B., and Punyavachira P. Induction of labor with vaginal misoprostol for second trimester termination of pregnancy in the scarred uterus. Int J Gynaecol Obstet 83 (2003) 293-297
49. Dickinson J.E. Misoprostol for second-trimester pregnancy termination in women with a prior cesarean delivery. Obstet Gynecol 105 (2005) 352-356
50. Faúndes A., Leocadio E., and Andalaft J. Making legal abortion accessible in Brazil. Reprod Health Matters 10 (2002) 120-127
51. FLASOG Report. Pre-Congress Workshop on Sexual and Reproductive Rights (2002), FLASOG, Santa Cruz de la Sierra, Bolivia
52. FLASOG Committee on Sexual and Reproductive Rights and Committee for Reducing Maternal and Perinatal Mortality. Report of Pre-Congress Workshop (2005), FLASOG, Santo Domingo, Dominican Republic